[HTML][HTML] Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
PM George, AU Wells, RG Jenkins - The Lancet. Respiratory …, 2020 - europepmc.org
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
[引用][C] Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
PM George, AU Wells, RG Jenkins - The Lancet Respiratory Medicine, 2020 - cir.nii.ac.jp
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Peter M George, Athol U Wells, R Gisli Jenkins
Lancet, 2020 - thelancet.com
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
PM George, AU Wells, RG Jenkins - The Lancet Respiratory Medicine, 2020 - Elsevier
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
[PDF][PDF] Peter M George, Athol U Wells, R Gisli Jenkins
2020 - iex.nl
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
[PDF][PDF] Peter M George, Athol U Wells, R Gisli Jenkins
2020 - beursduivel.be
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
[HTML][HTML] Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
PM George, AU Wells, RG Jenkins - The Lancet. Respiratory …, 2020 - ncbi.nlm.nih.gov
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
[引用][C] Peter M George, Athol U Wells, R Gisli Jenkins
2020
[引用][C] Peter M George, Athol U Wells, R Gisli Jenkins
2020